TAT and Stroke: Despite the undeniably deleterious neuropathology of HIV-1 Tat protein, high-throughput in in vitro and in vivo studies demonstrated dose-dependent anti-stroke neuroprotection of HIV-1 Tat-derived Tat peptides and their RRP analogues [22,83,84].